Climb Bio (@climbbio) 's Twitter Profile
Climb Bio

@climbbio

We believe elevating relationships leads to more meaningful insights, better answers, and ultimately, to more inspired medicines for patients

ID: 1447182630970134530

linkhttp://climbbio.com calendar_today10-10-2021 12:51:56

51 Tweet

54 Followers

56 Following

Climb Bio (@climbbio) 's Twitter Profile Photo

Climb Bio is excited to attend the Leerink Healthcare Therapeutics Forum. We're looking forward to engaging with fellow innovators and investors and discussing the future of immunology. Let’s connect! $CLYM #ClimbHigher #Leerink #InvestorConference

Climb Bio is excited to attend the Leerink Healthcare Therapeutics Forum. We're looking forward to engaging with fellow innovators and investors and discussing the future of immunology. Let’s connect!

$CLYM #ClimbHigher #Leerink #InvestorConference
Climb Bio (@climbbio) 's Twitter Profile Photo

Climb Bio is attending the BTIG Virtual Biotechnology Forum. Looking forward to connecting with healthcare innovators. $CLYM #HealthcareInnovation #BTIGBiotech

Climb Bio is attending the BTIG Virtual Biotechnology Forum. Looking forward to connecting with healthcare innovators.

$CLYM #HealthcareInnovation #BTIGBiotech
Climb Bio (@climbbio) 's Twitter Profile Photo

#ICYMI Dosed patients in budoprutug ITP & SLE trials Expect to initiate Ph2 pMN and Ph1 SC formulation trials soon Anti-APRIL antibody CLYM116 on track to submit IND or CTA in IgA nephropathy in H2 2025 Details to come on September investor event 🔗 loom.ly/34FrNk0

Climb Bio (@climbbio) 's Twitter Profile Photo

CLYM116 Advancing Toward Clinical Development Innovation is core to Climb’s #YearOfExecution. Through our exclusive license with Mabworks, CLYM116 remains on track to submit an IND or CTA in IgAN in H2 2025. Don’t miss our investor event—preclinical data coming in September.

Climb Bio (@climbbio) 's Twitter Profile Photo

#ICYMI: Climb Bio kicks off September @ CantorHCC in NYC! 🗓️ Sept 5 | 10:55 a.m. ET: Fireside chat w/ CEO Aoife Brennan, CMO Edgar Charles, and CBO Perrin Wilson Webcast: loom.ly/ytfUCfk Press release: loom.ly/qm7uF-wnews-ev… #CantorHCC

#ICYMI: Climb Bio kicks off September @ CantorHCC in NYC!

🗓️ Sept 5 | 10:55 a.m. ET: Fireside chat w/ CEO Aoife Brennan, CMO Edgar Charles, and CBO Perrin Wilson

Webcast: loom.ly/ytfUCfk

Press release: loom.ly/qm7uF-wnews-ev…

#CantorHCC
Climb Bio (@climbbio) 's Twitter Profile Photo

We’re hosting a webcast on CLYM116, our anti-APRIL antibody for IgAN, on Sept 29 at 8AM ET. Learn more about our approach: loom.ly/qm7uF-w #CLYM116 #IgAN #AutoimmuneResearch #ClimbBio #InvestorRelations

We’re hosting a webcast on CLYM116, our anti-APRIL antibody for IgAN, on Sept 29 at 8AM ET. Learn more about our approach: loom.ly/qm7uF-w

#CLYM116 #IgAN #AutoimmuneResearch #ClimbBio #InvestorRelations
Climb Bio (@climbbio) 's Twitter Profile Photo

$CLYM continues its September investor lineup John Baird Global Healthcare Conference! 🗓️ Tuesday, Sept 9 🕓 4:20 p.m. ET | Fireside chat w/ CEO Aoife Brennan and CBO Perrin Wilson Webcast: loom.ly/qm7uF-w #BairdConference #HealthcareInnovation #IR

$CLYM continues its September investor lineup <a href="/Baird/">John Baird</a> Global Healthcare Conference!

🗓️ Tuesday, Sept 9
🕓 4:20 p.m. ET | Fireside chat w/ CEO Aoife Brennan and CBO Perrin Wilson

Webcast: loom.ly/qm7uF-w

#BairdConference #HealthcareInnovation #IR
Climb Bio (@climbbio) 's Twitter Profile Photo

$CLYM will be at the Morgan Stanley Annual Global Healthcare Conference on Wed Sept 10. Our team looks forward to one-on-one investor meetings and connecting with leaders across the healthcare space. #ClimbBio #MorganStanleyHealthcare #InvestorRelations

$CLYM will be at the Morgan Stanley Annual Global Healthcare Conference on Wed Sept 10.

Our team looks forward to one-on-one investor meetings and connecting with leaders across the healthcare space.

#ClimbBio #MorganStanleyHealthcare #InvestorRelations
Climb Bio (@climbbio) 's Twitter Profile Photo

Don’t miss our webcast happening on Sept 29 at 8AM ET! We’ll share new preclinical data on CLYM116 and its potential to evolve IgAN treatment. 🔗 More details here: loom.ly/34FrNk0 #CLYM116 #IgAN #ClimbBio #InvestorRelations

Climb Bio (@climbbio) 's Twitter Profile Photo

$CLYM is excited to join the Stifel Virtual Immunology & Inflammation Forum on Sept 16. 🕥 10:30 a.m. ET: Presentation from CEO Aoife Brennan on advancing therapeutics for immune-mediated diseases. Webcast: loom.ly/a90xDL4 #StifelForum #Immunology #InvestorRelations

$CLYM is excited to join the Stifel Virtual Immunology &amp; Inflammation Forum on Sept 16.

🕥 10:30 a.m. ET: Presentation from CEO Aoife Brennan on advancing therapeutics for immune-mediated diseases.

Webcast: loom.ly/a90xDL4

#StifelForum #Immunology #InvestorRelations
Climb Bio (@climbbio) 's Twitter Profile Photo

Join $CLYM's webcast on 9/29 at 8AM ET to learn about CLYM116 program & the future of IgAN care. On deck: Aoife Brennan M.B., Ch.B.: CEO, $CLYM Edgar Charles, M.D., M.Sc.: CMO, $CLYM Craig Gordon, M.D., M.S.: Nephrologist, Tufts MC 🔗 loom.ly/a90xDL4

Climb Bio (@climbbio) 's Twitter Profile Photo

📢 Webcast: CLYM116 & the IgAN Opportunity 🗓️ Sept 29 | 8AM ET Hear from Climb Bio leaders + Dr. Craig Gordon on advancing therapies for IgA nephropathy. 🔗 loom.ly/a90xDL4 #CLYM116 #IgAN #ClimbBio

Climb Bio (@climbbio) 's Twitter Profile Photo

🚨 Happening soon! Join Climb Bio’s webcast on CLYM116 & IgAN today at 8AM ET. Learn about the current IgAN treatment landscape, unmet needs, and more: loom.ly/qm7uF-w #CLYM116 #IgAN

Climb Bio (@climbbio) 's Twitter Profile Photo

Please welcome Susan Altschuller, PhD, MBA as CFO at Climb Bio! She brings 20+ years of biopharma leadership, including CFO roles at Cerevel Therapeutics and ImmunoGen. Read more here: loom.ly/34FrNk0 $CLYM #CFO

Please welcome Susan Altschuller, PhD, MBA as CFO at Climb Bio!

She brings 20+ years of biopharma leadership, including CFO roles at Cerevel Therapeutics and ImmunoGen. 

Read more here: loom.ly/34FrNk0

$CLYM #CFO
Climb Bio (@climbbio) 's Twitter Profile Photo

Exciting news! Climb Bio’s abstract on CLYM116, our Fc-engineered anti-APRIL mAb for IgA nephropathy, has been accepted for #ASN2025. 📄Press Release: loom.ly/34FrNk0 ▶️ Webcast replay: loom.ly/1O-YdDc #CLYM116 #IgAN #Nephrology #ClimbBio #YearOfExecution